ASSOCIATIONS OF SERUM IONIZED CALCIUM, PHOSPHATE, AND PTH LEVELS WITH TECHNETIUM-99 SESTAMIBI PARATHYROID SPECT/CT SCAN IN PRIMARY

Size: px
Start display at page:

Download "ASSOCIATIONS OF SERUM IONIZED CALCIUM, PHOSPHATE, AND PTH LEVELS WITH TECHNETIUM-99 SESTAMIBI PARATHYROID SPECT/CT SCAN IN PRIMARY"

Transcription

1 ENDOCRINE PRACTICE Rapid Electronic Article in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited, typeset and finalized. This version of the manuscript will be replaced with the final, published version after it has been published in the print edition of the journal. The final, published version may differ from this proof. Original Article EP ASSOCIATIONS OF SERUM IONIZED CALCIUM, PHOSPHATE, AND PTH LEVELS WITH TECHNETIUM-99 SESTAMIBI PARATHYROID SPECT/CT SCAN IN PRIMARY HYPERPARATHYROIDISM. Thanh D. Hoang 1 ; Ami G. Jani 1 ; Vinh Q. Mai 1 ; Francois O. Tuamokumo 2 ; Mohamed K.M. Shakir 1 From: 1 Department of Endocrinology, Walter Reed National Military Medical Center, Bethesda, MD, United States, 20889; 2 Department of Research Programs, Walter Reed National Military Medical Center, Bethesda, MD, United States, Running title: Correlation of biomarkers with parathyroid scan Corresponding Author & reprint request: Dr. Thanh D. Hoang Division of Endocrinology, Walter Reed National Military Medical Center, 8901 Wisconsin Ave, Bethesda, MD thanh.d.hoang.mil@mail.mil

2 *No grant supports the writing of this paper. * Disclosure summary: The views expressed in this poster are those of the authors and do not necessarily reflect the official policy or position of the Department of the Army, Department of the Navy, Department of Defense, nor the U.S. Government. I certify that all individuals who qualify as authors have been listed; each has participated in the conception and design of this work, the analysis of data, the writing of the document, and the approval of the submission of this version; that the document represents valid work; that if we used information derived from another source, we obtained all necessary approvals to use it and made appropriate acknowledgements in the document; and that each takes public responsibility for it. Authors acknowledge that research protocol NNMC received applicable Institutional Review Board review and approval. Key words: Hyperparathyroidism, PTH, ionized calcium, serum phosphate, parathyroid scan

3 ABSTRACT Objective: To evaluate the relationship between various biochemical parameters in patients with PHPT with positive and negative technetium-99 sestamibi parathyroid scans SPECT/CT (Tc scan). Method: Retrospective analysis. Development of a logistic probability model. There were 218 patients with PHPT evaluated. Main outcome measures were serum total calcium, ionized calcium, intact PTH, albumin, alkaline phosphatase, phosphate, 25-hydroxy vitamin D, 1,25- dihydroxy vitamin D, 24-hour urine calcium levels and parathyroid adenoma weight. Results: Individually, using cut-off levels of 6.0 mg/dl for ionized calcium, 3.0 mg/dl for phosphate, and 90 pg/ml for intact PTH, we found that 91.3% (p=0.005), 70.7% (p=0.004) and 87.90% (p=0.023) of the patients had a positive Tc scan with their corresponding strengths of associations in the parentheses. Similar significant association was sustained in multivariate setting for serum ionized calcium (p = 0.015), phosphate (p=0.016) and intact PTH (p=0.028). A logistic probability model was designed to predict the probability of being positive for Tc scan given a set of covariates. Conclusion: There is a significant association between the levels of serum ionized calcium, phosphate, intact PTH, and the positivity of Tc scan. Further studies with larger patient populations are needed.

4 Abbreviations: BMD = Bone mineral density; BMI = body mass index; CT = computed tomography; CV = coefficient variation; DXA = dual-energy x-ray absorptiometry; GE = General Electric; PHPT = primary hyperparathyroidism; PTH = parathyroid hormone; MRI = magnetic resonance imaging; MET-PET-CT = C-11 methionine-positron emission tomographycomputed tomography scan; NIH = National Institutes of Health; PPV = positive predictive value; SPECT= single-photon emission computed tomography; Tc scan = technetium-99 sestamibi parathyroid scan. INTRODUCTION Primary hyperparathyroidism (PHPT) is a relatively common disorder of the inappropriate secretion of parathyroid hormone (PTH) from one or more of the parathyroid glands that leads to hypercalcemia. PHPT is often discovered incidentally; the majority of cases arise from a single parathyroid adenoma whereas 15% arise from hyperplastic glands (1). Most of the patients with PHPT are asymptomatic, but many may present with nephrolithiasis, decreased bone mass, or nonspecific symptoms such as weakness, fatigue, neuromuscular dysfunction, cardiovascular effects, and neuropsychiatric problems that may improve after parathyroidectomy. Prior to the advent of the technetium-99 sestamibi parathyroid scan (Tc scan), patients with PHPT underwent surgical bilateral neck exploration to assess all four parathyroid glands, which can be a long and tedious surgical procedure. The Tc scan was introduced in the early

5 1990s and has become a popular preoperative test to localize the parathyroid adenoma with the reported sensitivity of % and the positive predictive value of % (2, 3). Presently there are no well-established biochemical markers to predict the probability of a positive Tc scan in patients with PHPT. The objective of the study was to evaluate the relationship between various biochemical parameters in patients with positive and negative Tc scans. METHODS This study is a retrospective analysis of patients who were diagnosed with PHPT and seen at Walter Reed National Military Medical Center (previously National Naval Medical Center), Bethesda, MD, USA over a 14-year period. 265 patients with primary hyperparathyroidism were evaluated from We could not collect sufficient data on 47 patients. Out of these 47 excluded patients, 15 had recurrent disease. The diagnostic criteria for primary hyperparathyroidism are (a) elevated serum PTH level with elevated serum calcium level; (b) inappropriately normal PTH level with elevated serum calcium level; (c) elevated PTH level with normal calcium level; (d) calcium/cr clearance ratio >0.02. The intraoperative serum PTH was started in 2000 and this was performed in all patients who underwent surgery. A drop of > 50% PTH level intraoperatively suggested a successful removal of parathyroid adenoma. Exclusion criteria included persistent or recurrent disease after a prior neck exploration. Patients were divided into two groups: positive Tc scan (those with localized parathyroid adenoma) and negative Tc scan group (those with no localized parathyroid adenoma). During the study period, all imaging studies were performed with a Siemens singleheaded gamma camera (Trionix Biad, Twinsburg, OH) between The sensitivity and

6 specificity for this camera were 71% and 79%, respectively. Since 2006, Symbia T6 SPECT/CT (Siemens Medical Solutions, Hoffman Estates, IL) was used for parathyroid scanning with the sensitivity of 87% and specificity of 99%. Since 2016, we added GE Optima 640 SPECT/CT (GE Healthcare, Waukesha, WI) with the sensitivity of 82% and specificity of 78%. However, it is to be noted that the sensitivity for Tc scan with all these cameras is much lower with multiple parathyroid adenomas and hypercellular glands. Out of 218 patients, 30 patients were scanned with the Siemens camera and the remaining 188 patients were studied with the GE Optima and Symbia T6 SPECT/CT. The blood samples were drawn in a fasting state between a.m. in the morning because of the diurnal variation of serum PTH and calcium (4). Additionally, consumption of high phosphate containing foods may affect serum phosphate level (5). Laboratory data were analyzed by Quest Laboratory, including serum total calcium (corrected for albumin), ionized calcium, intact PTH, albumin, alkaline phosphatase, phosphate, 25-hydroxy vitamin D, 1,25-dihydroxy vitamin D, magnesium, and 24-hour urine calcium levels. Parathyroid adenoma weight and histology were performed by the Pathology Department of Walter Reed National Military Medical Center. The intra-assay coefficient variation (C.V.) for ionized calcium was 2.02% and the inter-assay C.V. was 5.05%. The intra-assay C.V. for serum total calcium was 2.70% and inter-assay C.V. was 2.80%. Similar values for PTH were 2.82% and 4.81%, respectively. Serum intact PTH levels were determined by immunoradiometric assay (Quest Laboratory, San Juan Capistrano, CA). All patients underwent preoperative diagnostic imaging of the parathyroid glands by utilizing Tc scan with or without neck ultrasonography. In some patients, computed tomography (CT) and magnetic resonance imaging (MRI) of the parathyroid glands were also performed at the discretion of the treating physicians. Scintigraphy was performed with the use of a gamma

7 camera after injection of 15 to 20 mci of 99mTc-Sestamibi. The preoperative Tc scan was considered positive if the report revealed an adenoma localization. When ultrasonography of the neck was performed, it was done with an HDI-5000 ultrasound machine (ATL, Seattle, WA). CT scanning and MRI were performed by using a GE Highspeed CT scanner (General Electric, Milwaukee, WI) and a GE Horizon MRI scanner (General Electric, Milwaukee, WI), respectively. BMD measurement was performed with the use of either a Hologic QDR 2000 (Hologic, Waltham, MA) or a Norland XR-26 Mark II (Norland, Fort Atkinson, WI) dual-energy x-ray absorptiometry bone densitometer (DXA). Parathyroid surgery was performed based on criteria for parathyroidectomy (NIH criteria published in 2004) and patient preference in both Tc scan positive and Tc scan negative groups (6). DATA ANALYSIS Statistical analysis was performed to determine if there are any differences or associations between each of the aforementioned variables and Tc scan (positive/negative), using either the Wilcoxon rank sum test for the numerical variables or the Fisher s exact for the categorical variables. Several cut-off points for ionized calcium, phosphate and intact PTH levels were tested for associations with Tc scan positivity. Three variables, serum ionized calcium (cut-off point 6.0 mg/dl), phosphate (cut-off point 3.0 mg/dl), and intact parathyroid levels (cut-off point 90 pg/ml) that showed significant associations with Tc scan positivity at their cut-off points were used in a binary logistic regression model to determine if their significances were sustained in the multivariate setting. Subsequently, a multivariate logistic regression model was fitted to the data using these variables for predictive interest. The following logistic probability model was used

8 , where is the probability of being positive for Tc scan for a given set of covariates. The estimated parameters of the model are: Thus, for an individual whose serum phosphate level is less than 3.0 mg/dl (that is, x1 = 1), serum intact parathyroid level is higher than 90 pg/ml (that is, x2 = 1), and serum ionized calcium is greater than 6.0 mg/dl (that is, x3 = 1), there is a 93.2% chance (probability) of observing a positive scan. RESULTS There were 218 patients with PHPT in the study whose age ranged from 22 to 91 years with a 1.95:1 female-to-male ratio (Table 1), 138 patients with positive Tc scans (63.8% female, 36.2 % male); and 80 patients with negative Tc scans (30% male, 70 % female). Out of those patients who underwent parathyroid surgery, 113 had adenoma, 16 had hypercellular gland, one with parathyroid cancer, and one with multiglandular disease. Those with positive Tc scans were found to have higher parathyroid adenoma weight (mean = 569 mg) compared to those with negative Tc scan (mean =140 mg). The average values for serum total calcium, ionized calcium, phosphate and PTH levels were ± 0.54 mg/dl, 6.13 ± 0.42 mg/dl, 2.58 ± 0.58 mg/dl, and ± pg/ml, respectively, for the positive Tc scan group and ± 0.75 mg/dl, 5.99 ± 0.57 mg/dl, 2.82 ± 0.68 mg/dl, and ± pg/ml, respectively, for the negative Tc scan group (Table 2). Of all the biomarkers evaluated, only three (serum ionized calcium, phosphate, and intact PTH levels) were found to significantly correlate with parathyroid

9 scan positivity. The cut-off levels for ionized serum calcium were arbitrarily determined with the range from lowest to highest values ( mg/dl) with a good sensitivity (Table 3). For serum phosphate, the cut-off level was also arbitrarily chosen with the range from mg/dl. Values of 2.5 and 3.0 mg/dl were significant when correlating with positive Tc scan. Serum phosphate levels of 2.0 and 1.5 mg/dl did not show any significant correlation and we cannot explain the lack of correlation. It is possible the relatively small number of patients with these serum phosphate levels may be responsible for this discrepancy. Other biomarkers such as alkaline phosphatase, 25-hydroxy vitamin D, 1,25-dihydroxy vitamin D, 24-hour urinary calcium, magnesium, and albumin were not significant. There were 7 patients with normocalcemic hyperparathyroidism. Out of these 7 patients, 3 underwent surgery (pathology confirmed parathyroid adenoma in all of them). The surgery was performed in the 3 patients because of patient preference and other criteria. In this study, 206 patients had neck ultrasound performed. All of these patients have normal thyroid function tests and 35 patients had benign thyroid nodules. In this group, neck ultrasound revealed parathyroid adenoma in 88 patients and did not localize parathyroid adenoma in 118 patients. The maximum cut-off point for serum ionized calcium at which an association was established was 6.7 mg/dl, with a corresponding p-value of At a cut-off point of 6.8 mg/dl, the p-value became 0.335, indicating no association. Using a cut-off level of 6.6 mg/dl for serum ionized calcium, 91% of the patients had a positive Tc scan (Table 3). For serum phosphate levels, the minimum cut-off point at which an association was established was 2.5 mg/dl, with a p-value of (Table 3). There is about two times more probability for positive Tc scan for an individual whose serum phosphate is at 2.5 mg/dl. For serum intact PTH levels,

10 at a cut-off point of 90 pg/ml, an association (p-value = 0.023) between serum intact PTH level and Tc scan positivity was observed (Table 3). There is approximately 7 times the likelihood of detecting a positive Tc scan for an individual whose serum intact PTH level is at least 90 pg/l or greater compared to an individual with PTH less than 90 pg/ml. These three variables, serum ionized calcium (cut-off point 6.0 mg/dl), phosphate (cut-off point 3.0 mg/dl), and intact PTH level (cut-off point 90 pg/ml) that showed significant associations at their cut-off points with Tc scan positivity also showed sustained significance in multivariate setting using the binary logistic regression model (Table 4). Age and gender did not affect the true positive rates of the Tc scan. In the positive Tc scan group (138 patients) (Figure 1): Of the 103 patients who had surgery, 91 patients were confirmed to have a single adenoma and 12 with hypercellular gland. There were 39 patients with nephrolithiasis. Dual-energy X-ray absorptiometry (DXA) showed normal findings in 42 patients, osteopenia in 59 patients, osteoporosis in 31 patients. Six patients did not have DXA scan performed. Thyroid ultrasound was positive for parathyroid adenoma in 65 patients, negative for 67 patients and not done in 6 patients with positive parathyroid scan. In the negative Tc scan group (80 patients) (Figure 1): Out of 28 patients who underwent parathyroidectomy, there were 22 patients with a parathyroid adenoma, 4 with hypercellular gland, 1 with a parathyroid carcinoma, and 1 with multiglandular disease. There were 17 patients with history of nephrolithiasis. DXA showed 23 patients with normal scan, 28 with osteopenia, 25 with osteoporosis; and 4 patients did not have DEXA scan

11 performed. Thyroid ultrasound was positive for parathyroid adenoma in 23 patients, negative in 51 patients, and not done in 6 patients. Obese vs non-obese patients with primary hyperparathyroidism: There were 129 non-obese patients (59.17%) (BMI <30 kg/m 2 ) and 89 obese patients (40.83%) (BMI>30 kg/m 2 ). For the non-obese patients, 77 had positive Tc scan (59.7%) and 52 with negative Tc scan (40.3%). For the obese patients, there were 61 patients with positive Tc scan (68.5%) and 28 with negative Tc scan (31.5%). For the non-obese patients who underwent surgery, there were 66 parathyroid adenomas, 1 parathyroid cancer, and 9 hypercellular gland. For the obese patients who underwent surgery, there were 54 parathyroid adenomas and 4 hypercellular parathyroid cases (7,8). DISCUSSION Our retrospective study demonstrates that the serum ionized calcium, intact PTH, and phosphate levels may be useful to predict the likelihood of localization on Tc scan. Other biomarkers such as alkaline phosphatase, 25-hydroxy vitamin D, 1, 25-dihydroxy vitamin D, 24- hour urinary calcium, magnesium, and parathyroid adenoma weight were not predictive in determining likelihood of detection of parathyroid adenoma on scintigraphy. Age and gender also had no effect on predicting localization. Preoperatively, the patient with parathyroid cancer presented with the same features like a parathyroid adenoma and because of this, we wanted to include it in the analysis. The parathyroid cancer was diagnosed postoperatively by histology. In this patient, serum PTH and serum calcium were moderately elevated, similar to that seen in a parathyroid adenoma.

12 There are limited number of studies that have correlated serum calcium levels with the parathyroid localization on Tc scans (9,10). One study reported a strong correlation of greater than 95% with Tc scan positivity when serum total calcium level is greater than 11.3 mg/dl (9). Another study reported decreased localization when serum total calcium level was less than mg/dl (10). However, correlation of serum ionized calcium levels with Tc scan was not reported in these studies. It was found that serum total calcium frequently does not correlate with serum ionized calcium in classifying calcium status and measurement of serum ionized calcium is recommended to accurately evaluate the calcium states (11). Our study found that lower serum total calcium levels correlate with decreased sensitivity on Tc scan and that serum ionized calcium level is a useful predictor of Tc scan positivity. In our study, a serum ionized calcium level of 6.6 mg/dl predicted a 91% probability of a positive Tc scan (p=0.005). We also observed that there is approximately five times the chance of positive Tc scan in patients whose serum ionized calcium level is above 6.0 mg/dl relative to those below 6.0 mg/dl. Interestingly, serum total corrected calcium levels were elevated in Tc scan positive patients (11.27 ± 0.54) compared to Tc scan negative patients (11.10 ± 0.75), but it was not statistically significant. Unlike other previous studies in which PTH levels did not correlate with diagnostic sensitivity (9,12), we found a relationship between serum intact PTH levels and positive Tc scans. We observed that there was about two times (the odds ratio) the chance of detecting a positive Tc scan in an individual whose serum intact PTH level is above 90 pg/ml relative to an individual with intact PTH below 90 pg/ml. Mean serum intact PTH levels in both positive and negative scans were ± pg/ml and ± pg/ml, respectively (p=0.032). Interestingly, correlation between serum intact PTH level and localization of parathyroid adenoma on Tc scan has been mixed and the reason for this mixed correlation is not clear (12-

13 15). It was apparent that high PTH levels (mean of 508 pg/ml) reported high sensitivity but at lower levels the data seemed mixed (12). Chiavistelli et al. theorized that the mixed results at lower PTH values may be due to the pulsatile nature of PTH secretion over a 24-hour period (16); whereas serum total and ionized calcium levels may be more stable. Timing of blood draws may have an impact on peak vs nadir PTH values (4,16); and in our study all blood samples were drawn between a.m. in a fasting state. Serum phosphate levels may be decreased or low normal in patients with primary hyperparathyroidism. The mean phosphate level for our total patient population was 2.7 mg/dl, with a range of mg/dL (reference range: mg/dl). In our study, we found phosphate levels to have significant association with positive Tc scan at a cut-off point of 3.0 mg/dl both individually (p=0.004) and in multivariate setting (p=0.016) along with serum ionized calcium and PTH levels. Few studies have investigated serum phosphate levels in positive and negative Tc scan group. Although, it has been found that phosphate levels were low in patients with positive scan, the data on its significance has been mixed (17,18). In our study, we found similar but significant results with average phosphate levels of 2.58±0.58 mg/dl in positive parathyroid group and 2.82±0.68 in those with negative scan with p-value of It is interesting that there was no significant association of positive Tc scan at serum phosphate levels less than 2.5 mg/dl since we expect severe PHPT is usually associated with low serum phosphate levels due to phosphaturic effect of PTH. The possible explanation for this finding may be due to limited role of phosphate in cellular uptake and wash out mechanism of Tc scan (18). Recently it has been reported that other imaging modalities or a combination of various imaging modalities can increase the sensitivity of parathyroid localization over Tc scan (19). In cases of normocalcemic or mild hypercalcemic hyperparathyroidism with levels below the serum

14 ionized calcium cutoff of 6.0 mg/dl, we recommend additional imaging studies such as ultrasound or 4D CT scan in conjunction with Tc scan if additional localization studies are pursued. Cheung et al. reported Tc scan (sensitivity 71-79%, PPV 72-95%) and single-photon emission computed tomography (SPECT) (sensitivity of 79-81%, PPV 91-95%) (20). SPECT for parathyroid adenoma localization increased the detection rate compared to planar imaging as demonstrated in one study (21). In the present study, the sensitivity and specificity for the Tc scan range from 71-87% and 78-99%, respectively. Other imaging modalities such as ultrasound (sensitivity 64-91%, PPV 83-96%), 4D-CT (sensitivity 70-81%, PPV 88-99%) and C-11 methionine-positron emission tomography-computed tomography (MET-PET-CT) scan (sensitivity 79-90%, PPV93-94%) should also be considered to improve detection rates in patient with low ionized calcium levels (20, 22, 23). Limitations of our study include an overall small cohort and the retrospective nature of the study. Generally, younger patients will likely have normal BMD compared with older subjects, despite significant hyperparathyroidism. We did not control for image acquisition and processing techniques which may have influenced parathyroid optimization and scan sensitivity in our patients. Further studies with larger patient populations may elucidate predictive factors in determining parathyroid localization. Ultimately, we conclude that all patients should undergo testing for serum ionized calcium, intact PTH, and phosphate levels which may be beneficial in determining the likelihood of parathyroid adenoma localization, using our logistic probability model. REFERENCES

15 1. Thompson NW, Eckhauser FE, Harness JK. The anatomy of primary hyperparathyroidism. Surgery. 1982;92: Shepherd JJ, Burgess JR, Greenaway TM, Ware R. Preoperative parathyroid scanning and surgical findings at bilateral, unilateral, or minimal reoperation for recurrent hyperparathyroidism after subtotal parathyroidectomy in patients with multiple endocrine neoplasia type 1. Arch Surg. 2000;135: Lumachi F, Zucchetta P, Angelini F, et al. Tumors of the parathyroid glands. Changes in clinical features and in noninvasive localization studies sensitivity. J Exp Clin Cancer Res. 2000;19: Sinha TK, Miller S, Feming J, Khairi R, Edmondson J, Johnston CC Jr, Bell NH. Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab. 1975;41: Moore LW, Nolte JV, Gaber AO, Suki WN. Association of dietary phosphate and serum phosphorus concentration by levels of kidney function. Am J Clin Nutr. 2015;102: Eigelberger MS, Cheah WK, Ituarte PHG, Streja L, Duh Q-Y, Clark OH. The NIH Criteria for Parathyroidectomy in Asymptomatic Primary Hyperparathyroidism: Are They Too Limited? Annals of Surgery. 2004;239: Glenn JA, Yen TW, Javorsky BR, Rose BG, Carr AA, Doffek KM, Evans DB, Wang TS. Association between body mass index and multigland primary hyperparathyroidism. J Surg Res. 2016;202: Adam MA, Untch BR, Danko ME, Stinnett S, Dixit D, Koh J, Marks JR, Olson JA Jr. Severe obesity is associated with symptomatic presentation, higher parathyroid hormone

16 levels, and increased gland weight in primary hyperparathyroidism. J Clin Endocrinolol Metab. 2010;95: Parikshak M, Castillo ED, Conrad MF, Talpos GB. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative parathyroid scanning for primary hyperparathyroidism. Am Surg. 2003;69: Mshelia DS, Hatutale AN, Mokgoro NP, Nchabaleng ME, Buscombe JR, Sathekge MM. Correlation between serum calcium levels and dual-phase (99m)Tc-parathyroid parathyroid scintigraphy in primary hyperparathyroidism. Clin Physiol Funct Imaging. 2012;32: Ong GS, Walsh JP, Stuckey BG, Brown SJ, Rossi E, Ng JL, Nguyen HH, Kent GN, Lim EM. The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. J Clin Endocrinol Metab. 2012;97: Khorasani N, Mohammadi A. Effective factors on the sensitivity of preoperative parathyroid scanning for primary hyperparathyroidism. Int J Clin Exp Med. 2014;7: Westerdahl J, Bergenfelz A. Parathyroid scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. World J Surg. 2004;28: Vassy WM, Nelson HS, Jr., Mancini ML, Timaran CH, Hall NC, Smith GT. Minimally invasive parathyroidectomy: how effective is preoperative parathyroid scanning? Am Surg. 2003;69:

17 15. Goldstein RE, Billheimer D, Martin WH, Richards K. Parathyroid scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg. 2003;237: Chiavistelli S, Giustina A, Mazziotti G. Parathyroid hormone pulsatility: physiological and clinical aspects. Bone Res. 2015;3: Rahman HA, Haque JA, Sharmin, S. Sestamibi Positive Vs Negative Scan In Primary Hyperparathyroidism; A Clinical Dilemma. Bangladesh J. Nuclear Med. 2014;17: Güler S, Ayşegül Ö, Zeynep E, Özgül T, Hatice K. The Relationship Between Technetium-99m-Methoxyisobutyl Isonitrile Parathyroid Scintigraphy and Hormonal and Biochemical Markers in Suspicion of Primary Hyperparathyroidism. Mol Imaging Radionucl Ther. 2013; 22: Untch BR, Adam MA, Scheri RP, et al. Surgeon-performed ultrasound is superior to 99Tc-parathyroid scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg. 2011;212: Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19: Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m parathyroid SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery. 2002;131:

18 22. Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism--an evidencebased analysis. Langenbecks Arch Surg. 2009;394: Weber T, Maier-Funk C, Ohlhauser D, et al. Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg. 2013;257:

19 Number of Patients Entire Patient Population (n=218) Positive Tc Scan (n=138) Negative Tc Scan (n = 80) Figure 1. Comparison of clinical characteristics of entire population with positive and negative Technetium-99 sestamibi parathyroid (Tc) scan groups. DXA dual energy absorptiometry; ultrasound, positive for parathyroid adenoma; parathyroid adenoma; hypercellular parathyroid gland.

20 Table 1: Clinical characteristics of the entire patient population Clinical Characteristics Mean (Range) Age (years) 61 (22-91) Serum total calcium ( mg/dl) 11.2 ( ) Serum phosphate ( mg/dl) 2.7 ( ) Serum intact PTH (15-65 pg/ml) 173 ( ) Serum ionized calcium ( mg/dl) 6.1 ( ) 24hr urine calcium ( mg) 322 (24-945) Serum magnesium ( mg/dl) 2.2 ( ) 25-OH vitamin D ( ng/ml) 42.9 ( ) 1, 25 (OH) 2 vitamin D (20-80 pg/ml) 73 (6-588) Serum albumin ( g/dl) 4.5 ( ) Serum alkaline phosphate ( U/L) 109 (46-591) *Data are given as mean (range). The reference values are given in parenthesis. Abbreviations: PTH: parathyroid hormone 25-OH vitamin D: 25-hydroxy vitamin D 1,25 (OH)2 vitamin D: 1,25-dihydroxy vitamin D Tc scan: Technetium-99 sestamibi parathyroid scan

21 Table 2: Various biomarkers in the positive and negative-tc scan groups. Clinical Characteristics Positive Tc Scan (n=138) Negative Tc Scan (n = 80) P-value Serum total calcium, mg/dl 11.27± ± Serum phosphate, mg/dl 2.58± ± Serum intact PTH, pg/ml ± ± Serum ionized calcium mg/dl 6.13± ± hr urine calcium, mg ± ± Serum magnesium, mg/dl 2.24± ± OH vitamin D, ng/ml 42.58± ± , 25 (OH) 2 vitamin D, pg/ml 74.26± ± Serum albumin, g/dl 4.44± ± Serum alkaline phosphate, IU/L ± ± * Mean values of various biomarkers in both positive and negative Tc scan groups. Three biomarkers (serum ionized calcium, phosphate, and intact PTH levels) showed significant association with parathyroid scan. Abbreviations: PTH: parathyroid hormone 25-OH vitamin D: 25-hydroxy vitamin D 1,25 (OH)2 vitamin D: 1,25-dihydroxy vitamin D Tc scan: Technetium-99 sestamibi parathyroid scan

22 Table 3: Association of various cut-off points for serum ionized calcium, phosphate and intact PTH with Tc scan positivity and its statistical significance. Cut-off point Tc scan positivity P-value Odds ratio Serum ionized calcium(mg/dl) % Serum phosphate (mg/dl) % % Serum intact PTH (pg/l) % % *Association of various cut-off points for serum ionized calcium, phosphate, and intact PTH levels with Tc scan positivity. At serum ionized calcium level of 6.6 mg/dl, there was a 91.3% probability of positive Tc scan (p-value = 0.005, OR 6.7). At serum phosphate level of 2.5 mg/dl, there was a 72.6% probability of positive Tc scan (p-value = 0.024, OR 2). At serum intact PTH level of 90 pg/l, there was a 87.9% probability of positive Tc scan (p-value = 0.023, OR 2.33). Abbreviations: PTH: parathyroid hormone 25-OH vitamin D: 25-hydroxy vitamin D 1,25 (OH) 2 vitamin D: 1,25-dihydroxy vitamin D Tc scan: Technetium-99 sestamibi parathyroid scan

23 Table 4: Statistical significance of independent variables in multivariate setting Independent variable P-value Serum ionized calcium Serum intact parathyroid hormone Serum phosphate *Sustained significance of three variables, serum ionized calcium (cut-off point 6.0 mg/dl), phosphate (cut-off point 3.0 mg/dl), and intact parathyroid levels (cut-off point 90 pg/ml) in the multivariate setting using a binary logistic regression model.

Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones

Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) 30 yr-old woman with 7 yr history

More information

Normal PTH Levels in Primary Hyperparathyroidism: Still the Same Disease?

Normal PTH Levels in Primary Hyperparathyroidism: Still the Same Disease? Ann Surg Oncol (2011) 18:3437 3442 DOI 10.1245/s10434-011-1744-x ORIGINAL ARTICLE ENDOCRINE TUMORS Normal PTH Levels in Primary Hyperparathyroidism: Still the Same Disease? Amanda L. Amin, MD, Tracy S.

More information

hypercalcemia of malignancy hyperparathyroidism PHPT the most common cause of hypercalcemia in the outpatient setting the second most common cause

hypercalcemia of malignancy hyperparathyroidism PHPT the most common cause of hypercalcemia in the outpatient setting the second most common cause hyperparathyroidism A 68-year-old woman with documented osteoporosis has blood tests showing elevated serum calcium and parathyroid hormone (PTH) levels: 11.2 mg/dl (8.8 10.1 mg/dl) and 88 pg/ml (10-60),

More information

Parathyroid Imaging. A Guide to Parathyroid Surgery

Parathyroid Imaging. A Guide to Parathyroid Surgery Parathyroid Imaging A Guide to Parathyroid Surgery Primary Hyperparathyroidism (PHPT) 3 rd most common endocrine disorder after diabetes and hyperthyroidism Prevalence in women 2% Often discovered in asymptomatic

More information

Approach to a patient with hypercalcemia

Approach to a patient with hypercalcemia Approach to a patient with hypercalcemia Ana-Maria Chindris, MD Division of Endocrinology Mayo Clinic Florida 2013 MFMER slide-1 Background Hypercalcemia is a problem frequently encountered in clinical

More information

Association of Histological Findings with Tc-99m Sestamibi Parathyroid Imaging in Hyperfunctional Parathyroid Gland

Association of Histological Findings with Tc-99m Sestamibi Parathyroid Imaging in Hyperfunctional Parathyroid Gland http://www.banglajol.info/index.php/jninb Original Article Journal of National Institute of Neurosciences Bangladesh, January 2016, Vol. 2, No. 1 oissn 2518-6612 pissn 2410-8030 Association of Histological

More information

PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW DISCLOSURES

PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW DISCLOSURES PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW Miguel Hernandez Pampaloni, M.D., Ph.D. Chief, Nuclear Medicine Assistant Professor of Radiology UCSF Department of Radiology and Biomedical Imaging DISCLOSURES

More information

Minimally invasive parathyroidectomy

Minimally invasive parathyroidectomy Minimally invasive parathyroidectomy Jessica E. Gosnell MD Assistant Professor of Surgery March 22, 2011 1 Minimally invasive parathyroidectomy 1. What? 2. When? 3. How? 4. Convert? 5. What adjuncts? Primary

More information

Marcin Barczynski, 1 Aleksander Konturek, 2 Alicja Hubalewska-Dydejczyk, 2. Filip Gołkowski, 1 Stanislaw Cichon, 1 Piotr Richter, 1 Wojciech Nowak

Marcin Barczynski, 1 Aleksander Konturek, 2 Alicja Hubalewska-Dydejczyk, 2. Filip Gołkowski, 1 Stanislaw Cichon, 1 Piotr Richter, 1 Wojciech Nowak 3 rd Chair and Department of General Surgery 1 and Chair and Department of Endocrinology 2 Jagiellonian University, Medical College Head: Prof. Wojciech Nowak, MD, PhD INTRAOPERATIVE BILATERAL INTERNAL

More information

Research Article Primary Hyperparathyroidism: 11-Year Experience in a Single Institute in Thailand

Research Article Primary Hyperparathyroidism: 11-Year Experience in a Single Institute in Thailand International Endocrinology Volume 2012, Article ID 952426, 4 pages doi:10.1155/2012/952426 Research Article Primary Hyperparathyroidism: 11-Year Experience in a Single Institute in Thailand Poramaporn

More information

Outline. Parathyroid Localization Studies. Mira Milas MD, FACS Associate Professor of Surgery Director, The Thyroid Center

Outline. Parathyroid Localization Studies. Mira Milas MD, FACS Associate Professor of Surgery Director, The Thyroid Center Parathyroid Localization Studies Mira Milas MD, FACS Associate Professor of Surgery Director, The Thyroid Center Outline Clinical Context of Primary Hyperparathyroidism Ultrasound, Sestamibi, and Other

More information

Hyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012

Hyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012 Hyperparathyroidism: Operative Considerations Financial Disclosures: None Steven J Wang, MD FACS Associate Professor Dept of Otolaryngology-Head and Neck Surgery University of California, San Francisco

More information

4/20/2015. The Neck xt Exploration: Intraoperative Parathyroid Hormone (IOPTH) Testing During Surgical Parathyroidectomy. Learning Objectives

4/20/2015. The Neck xt Exploration: Intraoperative Parathyroid Hormone (IOPTH) Testing During Surgical Parathyroidectomy. Learning Objectives The Neck xt Exploration: Intraoperative Parathyroid Hormone (IOPTH) Testing During Surgical Parathyroidectomy Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning

More information

Primary hyperparathyroidism (HPT) has an incidence of

Primary hyperparathyroidism (HPT) has an incidence of Dual-Phase Tc-Sestamibi Imaging: Its Utility in Parathyroid Hyperplasia and Use of Immediate/ Delayed Image Ratios to Improve Diagnosis of Hyperparathyroidism Leonie Gordon, MD; William Burkhalter, MD;

More information

Case 4: 27 yr-old woman with history of kidney stones and hyperparathyroidism.

Case 4: 27 yr-old woman with history of kidney stones and hyperparathyroidism. Case 4: 27 yr-old woman with history of kidney stones and hyperparathyroidism. Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Hyperparathyroidism

More information

Role of Imaging in the Localization of Parathyroid Adenoma

Role of Imaging in the Localization of Parathyroid Adenoma Role of Imaging in the Localization of Parathyroid Adenoma Authors S A Kabir 1, Z Khanzada 2, S I Akhtar 3, S I Kabir 4, N Wariach 1, 1. Department of Surgery, Lincoln County Hospital, Lincoln LN2 5QY,

More information

RADIOGUIDED PARATHYROIDECTOMY IS SUCCESSFUL IN 98.7% OF SELECTED PATIENTS

RADIOGUIDED PARATHYROIDECTOMY IS SUCCESSFUL IN 98.7% OF SELECTED PATIENTS Original Article RADIOGUIDED PARATHYROIDECTOMY IS SUCCESSFUL IN 98.7% OF SELECTED PATIENTS Charles D. Livingston, MD, FACS ABSTRACT Objective: To examine an individualized approach to patients with primary

More information

The CaPTHUS Scoring Model revisited: Applicability from. with Primary Hyperparathyroidism

The CaPTHUS Scoring Model revisited: Applicability from. with Primary Hyperparathyroidism wjoes The CaPTHUS Scoring Model revisited: Applicability from a UK Cohort 10.5005/jp-journals-10002-1199 with Primary Hyperparathyroidism Original Article The CaPTHUS Scoring Model revisited: Applicability

More information

HPI joint pain/arthritis serum calcium 11.5 PTH 147pg/ml

HPI joint pain/arthritis serum calcium 11.5 PTH 147pg/ml HPI 45 yo female Increased calcium level during evaluation for joint pain/arthritis W/U showed serum calcium 11.5 and PTH 147pg/ml (Normal 11-67pg/ml) Otherwise asymptomatic PMH/PSH Arthritis Tonsillectomy

More information

Hyperparathyroidism. When to Suspect, How to Diagnose, When and How to Intervene. Johanna A. Pallotta, MD, FACP, FACE

Hyperparathyroidism. When to Suspect, How to Diagnose, When and How to Intervene. Johanna A. Pallotta, MD, FACP, FACE Hyperparathyroidism When to Suspect, How to Diagnose, When and How to Intervene Johanna A. Pallotta, MD, FACP, FACE Potential conflicts of interest: None Johanna A. Pallotta, MD Outline Definition of hyperparathyroidism

More information

THE ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM WITH DISORDERS OF THE THYROID GLAND AND CARPENTRY OUR EXPERIENCE

THE ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM WITH DISORDERS OF THE THYROID GLAND AND CARPENTRY OUR EXPERIENCE 24 MEDICINSKI GLASNIK / str. 24-30 Snežana Marinković, Nenad Laketić 1 THE ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM WITH DISORDERS OF THE THYROID GLAND AND CARPENTRY OUR EXPERIENCE Introduction Primary

More information

PRIMARY HYPERPARATHYROIDISM

PRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM HYPERPARATHYROIDISM Inappropriate excess secretion of Parathyroid Hormone in Primary Hyperparathyroidism Appropriate Hypersecretion in Secondary Hyperparathyroidism PTH and

More information

PRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM. Hyperparathyroidism Etiology. Common Complex Insidious Chronic Global Only cure is surgery

PRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM. Hyperparathyroidism Etiology. Common Complex Insidious Chronic Global Only cure is surgery ENDOCRINE DISORDER PRIMARY HYPERPARATHYROIDISM Roseann P. Velez, DNP, FNP Francis J. Velez, MD, FACS Common Complex Insidious Chronic Global Only cure is surgery HYPERPARATHYROIDISM PARATHRYOID GLANDS

More information

Comparison Of Sestamibi Scintigraphy And Ultrasonography In Preoperative Localization Of Primary Hyperparathyroidism

Comparison Of Sestamibi Scintigraphy And Ultrasonography In Preoperative Localization Of Primary Hyperparathyroidism ISPUB.COM The Internet Journal of Surgery Volume 16 Number 1 Comparison Of Sestamibi Scintigraphy And Ultrasonography In Preoperative Localization Of Primary S Nasiri, A Sorush, A Hashemi, F Mehrkhani,

More information

ORIGINAL ARTICLE. An Optimal Algorithm for Intraoperative Parathyroid Hormone Monitoring

ORIGINAL ARTICLE. An Optimal Algorithm for Intraoperative Parathyroid Hormone Monitoring ORIGINAL ARTICLE An Optimal Algorithm for Intraoperative Parathyroid Hormone Monitoring Melanie L. Richards, MD; Geoffrey B. Thompson, MD; David R. Farley, MD; Clive S. Grant, MD Background: A minimally

More information

HYPERPARATHYROIDIS M FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE

HYPERPARATHYROIDIS M FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE HYPERPARATHYROIDIS M FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE PROFESSOR OF SURGERY J I N N A H S I N D H M E D I C A L U N I V E R S I T Y PREAMBLE Anatomy & physiology of the

More information

ORIGINAL ARTICLE. Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism

ORIGINAL ARTICLE. Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism Elizabeth A. Mittendorf, MD; Christopher R. McHenry, MD ORIGINAL ARTICLE Background: Persistent

More information

Potential conflicts of interest: None

Potential conflicts of interest: None Hyperparathyroidism When to Suspect, How to Diagnose, When and How to Intervene November 6, 2013 Johanna A. Pallotta, MD, FACP, FACE Potential conflicts of interest: None Johanna A. Pallotta, MD Outline

More information

ORIGINAL ARTICLE. Sestamibi Scans and Intraoperative Parathyroid Hormone Measurement in the Treatment of Primary Hyperparathyroidism

ORIGINAL ARTICLE. Sestamibi Scans and Intraoperative Parathyroid Hormone Measurement in the Treatment of Primary Hyperparathyroidism ORIGINAL ARTICLE Sestamibi Scans and Intraoperative Parathyroid Hormone Measurement in the Treatment of Primary Hyperparathyroidism Eric J. Bergson, MD; Laura A. Sznyter, MD; Sanford Dubner, MD; Christopher

More information

Complementary sestamibi scintigraphy and ultrasound for primary hyperparathyroidism

Complementary sestamibi scintigraphy and ultrasound for primary hyperparathyroidism Nuclear Medicine and Biomedical Imaging Research Article Complementary sestamibi scintigraphy and ultrasound for primary hyperparathyroidism Yang Z 1,3 *, Li AY 2, Alexander G 3 and Chadha M 3 1 Department

More information

Parathyroid Disease Scenarios for the Practicing Clinician. Vijaya Chockalingam MD Faculty Endocrinologist Banner University Medical Center- Phoenix

Parathyroid Disease Scenarios for the Practicing Clinician. Vijaya Chockalingam MD Faculty Endocrinologist Banner University Medical Center- Phoenix Parathyroid Disease Scenarios for the Practicing Clinician Vijaya Chockalingam MD Faculty Endocrinologist Banner University Medical Center- Phoenix Clinical Scenario-1 73 year man (BK) with hypercalcemia

More information

Preoperative Tc-99m-sestamibi (MIBI) scintigraphy and

Preoperative Tc-99m-sestamibi (MIBI) scintigraphy and Otolaryngology Head and Neck Surgery (2006) 134, 316-320 ORIGINAL RESEARCH In Vivo Characterisation of Parathyroid Lesions by Use of Gamma Probe: Comparison With Ex Vivo Count Method and Frozen Section

More information

Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring

Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring Endocrine Journal 2009, 57 Or i g i n a l Advance Publication doi: 10.1507/endocrj. K10E-196 Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone

More information

Southern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism

Southern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism Southern Derbyshire Shared Care Pathology Guidelines Primary Hyperparathyroidism Please use this Guideline in Conjunction with the Hypercalcaemia Guideline Definition Driven by hyperfunction of one or

More information

PAPER. The Effectiveness of Radioguided Parathyroidectomy in Patients With Negative Technetium Tc 99m Sestamibi Scans

PAPER. The Effectiveness of Radioguided Parathyroidectomy in Patients With Negative Technetium Tc 99m Sestamibi Scans PAPER The Effectiveness of Radioguided Parathyroidectomy in Patients With Negative Technetium Tc 99m Sestamibi Scans Herbert Chen, MD; Rebecca S. Sippel, MD; Sarah Schaefer, NP Background: Many surgeons

More information

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine

Nuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine Nuclear Medicine Head and Neck Region Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine Thyroid scintigraphy Parathyroid scintigraphy F18-FDG PET examinations in head and neck cancer

More information

"Asymptomatic" Hyperparathyroidism: Reasons for Parathyroidectomy

Asymptomatic Hyperparathyroidism: Reasons for Parathyroidectomy "Asymptomatic" Hyperparathyroidism: Reasons for Parathyroidectomy Rebecca S. Sippel, M.D. Assistant Professor Department of Surgery Section of Endocrine Surgery University of Wisconsin Primary Hyperparathyroidism

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

Clinical Medicine Insights: Endocrinology and Diabetes 2013:6

Clinical Medicine Insights: Endocrinology and Diabetes 2013:6 Open Access: Full open access to this and thousands of other papers at http://www.la-press.com. Clinical Medicine Insights: Endocrinology and Diabetes Surgery for Primary Hyperparathyroidism in Patients

More information

Endocrine Surgery When to Refer and What We Do

Endocrine Surgery When to Refer and What We Do Endocrine Surgery When to Refer and What We Do None Disclosures W. Heath Giles, M.D., F.A.C.S. Surgery Residency Program Director Assistant Professor of Surgery What is Endocrine Surgery? Who performs

More information

PARATHYROID IMAGING. James Lee, MD Chief, Endocrine Surgery Co-Director NY Thyroid-Parathyroid Center Columbia University Medical Center

PARATHYROID IMAGING. James Lee, MD Chief, Endocrine Surgery Co-Director NY Thyroid-Parathyroid Center Columbia University Medical Center PARATHYROID IMAGING James Lee, MD Chief, Endocrine Surgery Co-Director NY Thyroid-Parathyroid Center Columbia University Medical Center NO DISCLOSURES Overview The hallmarks of the ideal test Benefits

More information

Bone and Renal Stone Disease in Patients Operated for Primary Hyperparathyroidism in Pakistan: Is the Pattern of Disease different from the West?

Bone and Renal Stone Disease in Patients Operated for Primary Hyperparathyroidism in Pakistan: Is the Pattern of Disease different from the West? ecommons@aku Section of Urology Department of Surgery August 1999 Bone and Renal Stone Disease in Patients Operated for Primary Hyperparathyroidism in Pakistan: Is the Pattern of Disease different from

More information

POSTER SESSION. Predictors of an Accurate Preoperative Sestamibi Scan for Single-Gland Parathyroid Adenomas

POSTER SESSION. Predictors of an Accurate Preoperative Sestamibi Scan for Single-Gland Parathyroid Adenomas POSTER SESSION Predictors of an Accurate Preoperative Sestamibi Scan for Single-Gland Parathyroid Adenomas Antonia E. Stephen, MD; Sanford I. Roth, MD; David W. Fardo, MS; Dianne M. Finkelstein, PhD; Gregory

More information

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE George N. Sfakianakis MD Professor of Radiology and Pediatrics Director, Division of Nuclear Medicine UM/JMMC Miami FL October 2009 ENDONCRINE

More information

INDEX. Note: Page numbers of issue and article titles are in boldface type. cell carcinoma. ENDOCRINE SURGERY

INDEX. Note: Page numbers of issue and article titles are in boldface type. cell carcinoma. ENDOCRINE SURGERY ENDOCRINE SURGERY INDEX Note: Page numbers of issue and article titles are in boldface type. Adenylate cyclase, in signal transduction 425-426 Adrenal incidentalomas, 499-509 imaging of, 502-504 in patients

More information

Preoperative Localization and Intraoperative Parathyroid Hormone Assay in Korean Patients with Primary Hyperparathyroidism

Preoperative Localization and Intraoperative Parathyroid Hormone Assay in Korean Patients with Primary Hyperparathyroidism Original Article Endocrinol Metab 2014;29:464-469 http://dx.doi.org/10.3803/enm.2014.29.4.464 pissn 2093-596X eissn 2093-5978 Preoperative Localization and Intraoperative Parathyroid Hormone Assay in Korean

More information

Perioperative parathormone assessment during surgery for primary hyperparathyroidism;

Perioperative parathormone assessment during surgery for primary hyperparathyroidism; 08. hoofdstuk 08 23-07-2001 09:52 Pagina 79 Perioperative parathormone assessment during surgery for primary hyperparathyroidism; Comparison of four techniques 8 Submitted for publication as Smit PC, Borel

More information

PTH > 60pg/ml PRIMARY HYPERPARATHYROIDISM. Introduction Biochemical Diagnosis. Normal Parathyroid. Parathyroid Glands

PTH > 60pg/ml PRIMARY HYPERPARATHYROIDISM. Introduction Biochemical Diagnosis. Normal Parathyroid. Parathyroid Glands next speaker: Declan Neeson Belfast/UK SPECT/CT scanning and parathyroid surgery in Southern Trust, N. Ireland D Neeson M Korda, G Gray, C Leonard, M Fawzy, R Lambon Parathyroid Glands PRIMARY HYPERPARATHYROIDISM

More information

Parathyroid Imaging: Current Concepts. Maria Gule-Monroe, M.D. Nancy Perrier, M.D.

Parathyroid Imaging: Current Concepts. Maria Gule-Monroe, M.D. Nancy Perrier, M.D. Parathyroid Imaging: Current Concepts Maria Gule-Monroe, M.D. Nancy Perrier, M.D. Disclosures None Objectives Ultrasound characteristics of parathyroid adenomas vs. lymph nodes 4D-CT evaluation of hyperparathyroidism

More information

The current status of intraoperative ipth assay in surgery for primary hyperparathyroidism

The current status of intraoperative ipth assay in surgery for primary hyperparathyroidism Review Article The current status of intraoperative ipth assay in surgery for primary hyperparathyroidism Marcin Barczyński 1, Filip Gołkowski 2, Ireneusz Nawrot 3 1 Department of Endocrine Surgery, Third

More information

ORIGINAL ARTICLE. Severity, Clinical Significance, Relationship to Primary Hyperparathyroidism, and Response to Parathyroidectomy

ORIGINAL ARTICLE. Severity, Clinical Significance, Relationship to Primary Hyperparathyroidism, and Response to Parathyroidectomy ORIGINAL ARTICLE Osteoporosis in Multiple Endocrine Neoplasia Type Severity, Clinical Significance, Relationship to Primary Hyperparathyroidism, and Response to Parathyroidectomy John R. Burgess, MD, FRACP;

More information

Parathyroid Imaging What is best

Parathyroid Imaging What is best Parathyroid Imaging What is best Mike Avison Bradford Why me? I m honoured to be asked to present this. There is no killer paper or text which clearly proves the best methodology. Bradford has performed

More information

Challenges in the Management of Primary HPTH. Zaher Ajam, MD Ghada El-Hajj Fuleihan, MD, MPH

Challenges in the Management of Primary HPTH. Zaher Ajam, MD Ghada El-Hajj Fuleihan, MD, MPH Challenges in the Management of Primary HPTH Zaher Ajam, MD Ghada El-Hajj Fuleihan, MD, MPH Case Presentation 1 This a case of a 41-year-old gentleman who is referred to Endocrinology clinic for low BMD,

More information

Peroperative PTH testing:

Peroperative PTH testing: 07. hoofdstuk 07 23-07-2001 09:52 Pagina 69 Peroperative PTH testing: confirmation of successful surgical treatment of primary hyperparathyroidism 7 Smit PC, Thijssen JHH, Borel Rinkes IHM, van Vroonhoven

More information

301 S. Westfield Rd., Suite 250 Madison, WI See inside for information about our Endocrine Surgery Referral Program

301 S. Westfield Rd., Suite 250 Madison, WI See inside for information about our Endocrine Surgery Referral Program 301 S. Westfield Rd., Suite 250 Madison, WI 53717 See inside for information about our Endocrine Surgery Referral Program December 2017 Dear Colleague, Thank you for referring your patient(s) to UW Health

More information

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 13, 2017 Disclosures statement: Consultant: Allena, Becker

More information

CURRENTLY THERE is considerable discussion about

CURRENTLY THERE is considerable discussion about 0013-7227/02/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 87(3):1024 1029 Printed in U.S.A. Copyright 2002 by The Endocrine Society Parathyroid Surgery: Separating Promise from Reality NANCY

More information

Six hundred fifty-six consecutive explorations for primary hyperparathyroidism Udelsman R

Six hundred fifty-six consecutive explorations for primary hyperparathyroidism Udelsman R Six hundred fifty-six consecutive explorations for primary hyperparathyroidism Udelsman R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS

More information

Surgical treatment of primary hyperparathyroidism due to parathyroid tumor: A 15-year experience

Surgical treatment of primary hyperparathyroidism due to parathyroid tumor: A 15-year experience ONCOLOGY LETTERS 12: 1989-1993, 2016 Surgical treatment of primary hyperparathyroidism due to parathyroid tumor: A 15-year experience LU FENG, XU ZHANG and SHAN TING LIU Department of Head and Neck Surgery,

More information

Hypercalcemia & Parathyroid Disorders. W. Reid Litchfield, MD, FACE, ECNU Desert Endocrinology

Hypercalcemia & Parathyroid Disorders. W. Reid Litchfield, MD, FACE, ECNU Desert Endocrinology Hypercalcemia & Parathyroid Disorders W. Reid Litchfield, MD, FACE, ECNU Desert Endocrinology Objectives Review diagnostic workup for hypercalcemia Review management of primary hyperparathyroidism Review

More information

Since the advent of multichannel serum chemistry

Since the advent of multichannel serum chemistry ONLINE EXCLUSIVE Padmaja Sanapureddy, MD; Vishnu Vardhan Garla, MD; Mallikarjuna Reddy Pabbidi, DVM, PhD Department of Primary Care and Medicine, G.V. (Sonny) Montgomery VA Medical Center, Jackson, Miss

More information

2016 Arizona AACE Meeting: Updated Guidelines for the Management of Primary Hyperparathyroidism (PHPT)

2016 Arizona AACE Meeting: Updated Guidelines for the Management of Primary Hyperparathyroidism (PHPT) 2016 Arizona AACE Meeting: Updated Guidelines for the Management of Primary Hyperparathyroidism (PHPT) Scott M. Wilhelm, MD, FACS Associate Professor and Section Head Endocrine Surgery University Hospitals-Cleveland

More information

A Move Towards Focused Parathyroidectomy in BSMMU Even Under Local Anesthesia

A Move Towards Focused Parathyroidectomy in BSMMU Even Under Local Anesthesia 40 A Move Towards Focused Parathyroidectomy in BSMMU Even Under Local Anesthesia Jawhar Lal Singha 1, Saifuddin Ahmed 2, AHM Towhidul Alam 3, Nasim Sobhan Khondokar 4, Syed Serajul Karim 5 1 MS Student,

More information

Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from it?

Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from it? Zawawi et al. Journal of Otolaryngology - Head and Neck Surgery 2013, 42:56 ORIGINAL RESEARCH ARTICLE Open Access Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from

More information

ORIGINAL ARTICLE. Appearance of Ectopic Undescended Inferior Parathyroid Adenomas on Technetium Tc 99m Sestamibi Scintigraphy

ORIGINAL ARTICLE. Appearance of Ectopic Undescended Inferior Parathyroid Adenomas on Technetium Tc 99m Sestamibi Scintigraphy ORIGINAL ARTICLE Appearance of Ectopic Undescended Inferior Parathyroid Adenomas on Technetium Tc 99m Sestamibi Scintigraphy A Lesson From Reoperative Parathyroidectomy David Axelrod, MD; James C. Sisson,

More information

Iperparatiroidismo normocalcemico: vero o falso?

Iperparatiroidismo normocalcemico: vero o falso? Iperparatiroidismo normocalcemico: vero o falso? Bari, 7-10 novembre 2013 TERAPIA E FOLLOW-UP A. Piovesan SCDU Endocrinologia Oncologica AO Città della Salute e della Scienza Molinette Torino THE THIRD

More information

IMPACT OF CONCOMITANT THYROID PATHOLOGY ON PREOPERATIVE WORKUP FOR PRIMARY HYPERPARATHYROIDISM

IMPACT OF CONCOMITANT THYROID PATHOLOGY ON PREOPERATIVE WORKUP FOR PRIMARY HYPERPARATHYROIDISM January 28, 2009 EUROPEAN JOURNAL OF MEDICAL RESEARCH 37 Eur J Med Res (2009) 14: 37-41 I. Holzapfel Publishers 2009 IMPACT OF CONCOMITANT THYROID PATHOLOGY ON PREOPERATIVE WORKUP FOR PRIMARY HYPERPARATHYROIDISM

More information

Coexistence of parathyroid adenoma and papillary thyroid carcinoma. Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park

Coexistence of parathyroid adenoma and papillary thyroid carcinoma. Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park J Korean Surg Soc 2011;81:316-320 http://dx.doi.org/10.4174/jkss.2011.81.5.316 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Coexistence of parathyroid

More information

Index. radiologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. radiologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACC. See Adrenal cortical carcinoma. Acromegaly and the pituitary gland, 551 Acute suppurative thyroiditis, 405, 406 Addison, Thomas and

More information

Original Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism

Original Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism www.ijcem.com/ijcem807001 Original Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism Itoko Hisa 1, Hiroshi Kaji 1, Yoshifumi

More information

Diagnosis and Treatment of Primary Hyperparathyroidism. Geoffrey B. Thompson, MD Professor of Surgery College of Medicine, Mayo Clinic

Diagnosis and Treatment of Primary Hyperparathyroidism. Geoffrey B. Thompson, MD Professor of Surgery College of Medicine, Mayo Clinic Diagnosis and Treatment of Primary Hyperparathyroidism Geoffrey B. Thompson, MD Professor of Surgery College of Medicine, Mayo Clinic Disclosure Nothing to Disclose Primary HPT Autonomous secretion of

More information

Cases in Endocrinology

Cases in Endocrinology Bones, Moans and Groans Diagnosing and Treating Primary Hyperparathyroidism By M. Usman Chaudhry, MD Table 1 Laboratory parameters Her bone density had osteopenic T-Scores of -2.3 at lumbar spine, and

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern

More information

Radiographic Appearance Of Primary Hyperparathyroidism With Atypical Parathyroid Adenoma

Radiographic Appearance Of Primary Hyperparathyroidism With Atypical Parathyroid Adenoma ISPUB.COM The Internet Journal of Internal Medicine Volume 6 Number 2 Radiographic Appearance Of Primary Hyperparathyroidism With Atypical Parathyroid Adenoma P George, N Philip, B Pawar Citation P George,

More information

Parathyroidectomy. Surgery for Parathyroid Problems

Parathyroidectomy. Surgery for Parathyroid Problems Parathyroidectomy Surgery for Parathyroid Problems Why You Need Parathyroid Surgery Has your doctor just recommended that you have parathyroid surgery? If so, you likely have many questions. What are the

More information

Clinical Approach to Hypercalcemia For the Primary Care Provider

Clinical Approach to Hypercalcemia For the Primary Care Provider Clinical Approach to Hypercalcemia For the Primary Care Provider Christina Maser, MD FACS UCSF Fresno Department of Surgery, Endocrine Surgery 2/2/19 Objectives Recognition of pitfalls of diagnosis of

More information

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019 Persistent post transplant hyperparathyroidism Shiva Seyrafian IUMS-97/10/18-8/1/2019 normal weight =18-160 mg In HPT= 500-1000 mg 2 Epidemiology Mild 2 nd hyperparathyroidism (HPT) resolve after renal

More information

Use of PTH at Point of Surgery for Non-Localized Cases of Hyperparathyoidism

Use of PTH at Point of Surgery for Non-Localized Cases of Hyperparathyoidism Use of PTH at Point of Surgery for Non-Localized Cases of Hyperparathyoidism Keck Hospital of USC Private, non-profit 400 bed hospital Teaching and research, USC Keck School of Medicine Approx. 40 parathyroid

More information

Adenoma weight and biochemical parameters in primary hyperparathyroidism

Adenoma weight and biochemical parameters in primary hyperparathyroidism Original Research Medical Journal of Islamic Republic of Iran, Vol. 25, No. 3, Nov. 2011, pp. 136-141 Adenoma weight and biochemical parameters in primary hyperparathyroidism Downloaded from mjiri.iums.ac.ir

More information

Diagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine.

Diagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine. Diagnosis and Treatment of Osteoporosis Department of Endocrinology and Metabolism Ajou University School of Medicine Yoon-Sok CHUNG WCIM, COEX, Seoul, 27Oct2014 Case 1 71-year old woman Back pain Emergency

More information

Re-explorative Parathyroid Surgery for Persistent and Recurrent Primary Hyperparathyroidism

Re-explorative Parathyroid Surgery for Persistent and Recurrent Primary Hyperparathyroidism 10.5005/jp-journals-10002-1070 ORIGINAL ARTICLE WJOES Re-explorative Parathyroid Surgery for Persistent and Recurrent Primary Hyperparathyroidism Rachel L O Connell, Karolina Afors, Martin H Thomas Ashford

More information

Functional evaluation of parathyroid adenoma using

Functional evaluation of parathyroid adenoma using Original article Functional evaluation of parathyroid adenoma using 99m Tc-MIBI parathyroid SPECT/CT: correlation with functional markers and disease severity Hyung-Jun Im a,c, In Ki Lee a, Jin Chul Paeng

More information

PAPER. An Algorithm to Maximize Use of Minimally Invasive Parathyroidectomy

PAPER. An Algorithm to Maximize Use of Minimally Invasive Parathyroidectomy PAPER An Algorithm to Maximize Use of Minimally Invasive Parathyroidectomy Roderick M. Quiros, MD; Joseph Alioto, BA; Scott M. Wilhelm, MD; Amjad Ali, MD; Richard A. Prinz, MD Hypothesis: Minimally invasive

More information

Intraoperative Parathyroid Hormone Monitoring Corroborates the Success of Parathyroidectomy in Children

Intraoperative Parathyroid Hormone Monitoring Corroborates the Success of Parathyroidectomy in Children J Clin Res Pediatr Endocrinol 2014;6(3):158-162 DO I: 10.4274/jcrpe.1401 Original Article Intraoperative Hormone Monitoring Corroborates the Success of ectomy in Children Ahmet Çelik1, Emre Divarcı1, Zafer

More information

Abhijit Thakur Æ Frederic Sebag Æ Eveline Slotema Æ Giuseppe Ippolito Æ David Taïeb Æ Jean François Henry

Abhijit Thakur Æ Frederic Sebag Æ Eveline Slotema Æ Giuseppe Ippolito Æ David Taïeb Æ Jean François Henry World J Surg (2009) 33:1219 1223 DOI 10.1007/s00268-009-0029-z Significance of Biochemical Parameters in Differentiating Uniglandular from Multiglandular Disease and Limiting Use of Intraoperative Parathormone

More information

Hypercalcemic Crisis in a Patient with a Huge Mediastinal Atypical Parathyroid Adenoma

Hypercalcemic Crisis in a Patient with a Huge Mediastinal Atypical Parathyroid Adenoma AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited,

More information

SPECT/CT Fusion in the Diagnosis of Hyperparathyroidism

SPECT/CT Fusion in the Diagnosis of Hyperparathyroidism SPECT/CT Fusion in the Diagnosis of Hyperparathyroidism Yoshio Monzen, Akihisa Tamura, Hajime Okazaki, Taichi Kurose, Masayuki Kobayashi, Masatsugu Kuraoka Department of Radiology, Hiroshima Prefectural

More information

This PDF is available for free download from a site hosted by Medknow Publications

This PDF is available for free download from a site hosted by Medknow Publications Original Article Role of radionuclide scintigraphy in the detection of parathyroid adenoma Singh N, Krishna BA Department of Nuclear Medicine, P. D. Hinduja National Hospital and MRC, Mumbai, India Correspondence

More information

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany PET-MRI in malignant bone tumours Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to PET/MRI General considerations Bone metastases Primary bone tumours

More information

Women s Health in General Practice Symposium 2015 Thyroid & Parathyroid Cases

Women s Health in General Practice Symposium 2015 Thyroid & Parathyroid Cases Women s Health in General Practice Symposium 2015 Thyroid & Parathyroid Cases Bill Fleming Epworth Freemasons Hospital 1 Common Endocrine Presentations anatomical problems thyroid nodule / goitre embryological

More information

Parathyroids, Small but Mighty Current Pathways to Early Diagnosis and Cure of Parathyroid Disease

Parathyroids, Small but Mighty Current Pathways to Early Diagnosis and Cure of Parathyroid Disease Parathyroids, Small but Mighty Current Pathways to Early Diagnosis and Cure of Parathyroid Disease Mira Milas MD, FACS Professor of Surgery Director of Endocrine Surgery No conflicts of interest or financial

More information

International Journal of Case Reports and Images (IJCRI)

International Journal of Case Reports and Images (IJCRI) www.edoriumjournals.com Case report peer REVIEWED OPEN ACCESS A parathyroid cyst associated with an adenoma causing primary hyperparathyroidism (PHPT): Gamma camera localization for case with MIBI scan-negative

More information

Comparison of indocyanine green fluorescence and parathyroid autofluorescence imaging in the identification of parathyroid glands during thyroidectomy

Comparison of indocyanine green fluorescence and parathyroid autofluorescence imaging in the identification of parathyroid glands during thyroidectomy Original Article Comparison of indocyanine green fluorescence and parathyroid autofluorescence imaging in the identification of parathyroid glands during thyroidectomy Bora Kahramangil, Eren Berber Department

More information

Primary Hyperparathyroidism

Primary Hyperparathyroidism Primary Hyperparathyroidism Copyright Copyright 2019 2019 American American Associa7on Associa7on of Clinical of Clinical Endocrinologists Endocrinologists 1 Primary Hyperparathyroidism In primary hyperparathyroidism

More information

Elena Castellano, Roberto Attanasio, Laura Gianotti, Flora Cesario, Francesco Tassone, and Giorgio Borretta

Elena Castellano, Roberto Attanasio, Laura Gianotti, Flora Cesario, Francesco Tassone, and Giorgio Borretta ORIGINAL ARTICLE Forearm DXA Increases the Rate of Patients With Asymptomatic Primary Hyperparathyroidism Meeting Surgical Criteria Elena Castellano, Roberto Attanasio, Laura Gianotti, Flora Cesario, Francesco

More information

O~iginalArtrc!~'" MINIMALLY INVASIVE RADIO-GUIDED PARATHYROIDECTOMY IN 152 CONSECUTIVE PATIENTS WITH PRIMARY HYPERPARATHYROIDISM

O~iginalArtrc!~' MINIMALLY INVASIVE RADIO-GUIDED PARATHYROIDECTOMY IN 152 CONSECUTIVE PATIENTS WITH PRIMARY HYPERPARATHYROIDISM O~iginalArtrc!~'",,_.~.~_.,_,,~_......_. ~.o:-'';:...:/-.~. ~'.:::.., MINIMALLY INVASIVE RADIO-GUIDED PARATHYROIDECTOMY IN 152 CONSECUTIVE PATIENTS WITH PRIMARY HYPERPARATHYROIDISM Douglas Politz, MD,

More information

Hungry Bone Syndrome (HBS) in Patients Operated for Primary Hyperparathyroidism (PHPT): A Six-Year Experience

Hungry Bone Syndrome (HBS) in Patients Operated for Primary Hyperparathyroidism (PHPT): A Six-Year Experience Philippine Journal Of Otolaryngology-Head And Neck Surgery Vol. 32 No. 2 July December 2017 Rhoda Zyra M. Padilla-Baraoidan, MD Maria Jocelyn Capuli-Isidro, MD Beinjerinck Ivan B. Cudal, MD Ayezl A. Embestro-Pontillas,

More information

Hyperparathyroidism, whether primary or secondary, is

Hyperparathyroidism, whether primary or secondary, is The Value of 99m Tc-Sestamibi SPECT/CT over Conventional SPECT in the Evaluation of Parathyroid Adenomas or Hyperplasia Isis W. Gayed, MD 1 ; E. Edmund Kim, MD 1 ; William F. Broussard, BS 1 ; Douglass

More information

A 20-Year Study on 190 Patients With Primary Hyperparathyroidism in a Developing Country: Turkey Experience

A 20-Year Study on 190 Patients With Primary Hyperparathyroidism in a Developing Country: Turkey Experience Int Surg 2015;100:648 655 DOI: 10.9738/INTSURG-D-14-00094.1 A 20-Year Study on 190 Patients With Primary Hyperparathyroidism in a Developing Country: Turkey Experience Arif Usta 1, Etem Alhan 2, Akif Cinel

More information

News on the treatment of HPT

News on the treatment of HPT News on the treatment of HPT G.C. Torre XIV Annual Conference of EES Tourin 25-27 November 2010 Epidemiology Prevalence: Sweeden = 4.3 /1000 Norway = 3/1000 Finland = 21/1000 USA = 1/1000 Italy = 5/1000

More information